Saunders Brent L

Saunders Brent L is listed in filings as Chairman of the Board and CEO at Bausch + Lomb Corporation. This profile follows SEC Form 4 activity through May 26, 2026, including purchase activity and sale activity. Recent filings connect the profile to Bausch + Lomb Corporation (BLCO), ARS Pharmaceuticals, Inc. (SPRY), and The Beauty Health Company (SKIN). The current snapshot covers public activity from Jun 24, 2024 to May 26, 2026. Reported amounts are shown as $45.9K to $451.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.